Chinese english Germany Japanese Korea

3,7-Anhydro-1-[5-carboxy-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]-1,6-dideoxy-β-D-gulo-5-octulose-1,4-furanuronic acid

3,7-Anhydro-1-[5-carboxy-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]-1,6-dideoxy-β-D-gulo-5-octulose-1,4-furanuronic acid Struktur
55728-23-9
CAS-Nr.
55728-23-9
Englisch Name:
3,7-Anhydro-1-[5-carboxy-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]-1,6-dideoxy-β-D-gulo-5-octulose-1,4-furanuronic acid
Synonyma:
Octosyl acid C;Octosylsaeure C;3,7-Anhydro-1-[5-carboxy-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]-1,6-dideoxy-β-D-gulo-5-octulose-1,4-furanuronic acid;β-D-gulo-5-Octulose-1,4-furanuronic acid, 3,7-anhydro-1-(5-carboxy-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-1,6-dideoxy- (9CI)
CBNumber:
CB22145080
Summenformel:
C13H12N2O10
Molgewicht:
356.24
MOL-Datei:
55728-23-9.mol
Request For Quotation

3,7-Anhydro-1-[5-carboxy-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]-1,6-dideoxy-β-D-gulo-5-octulose-1,4-furanuronic acid Eigenschaften

Dichte
1.853±0.06 g/cm3(Predicted)
pka
3.09±0.60(Predicted)

Sicherheit

3,7-Anhydro-1-[5-carboxy-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]-1,6-dideoxy-β-D-gulo-5-octulose-1,4-furanuronic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

3,7-Anhydro-1-[5-carboxy-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]-1,6-dideoxy-β-D-gulo-5-octulose-1,4-furanuronic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3,7-Anhydro-1-[5-carboxy-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]-1,6-dideoxy-β-D-gulo-5-octulose-1,4-furanuronic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
  • 3,7-Anhydro-1-[5-carboxy-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]-1,6-dideoxy-β-D-gulo-5-octulose-1,4-furanuronic acid
  • Octosyl acid C
  • Octosylsaeure C
  • β-D-gulo-5-Octulose-1,4-furanuronic acid, 3,7-anhydro-1-(5-carboxy-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-1,6-dideoxy- (9CI)
  • 55728-23-9
  • C13H12N2O10
Copyright 2019 © ChemicalBook. All rights reserved